Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4542532012 | Berotralstat hydrochloride (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
4542533019 | Berotralstat hydrochloride | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
4542543016 | Berotralstat dihydrochloride | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Berotralstat hydrochloride | Is a | Substance with kallikrein inhibitor mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
Berotralstat hydrochloride | Is a | Pyrazole and/or pyrazole derivative | true | Inferred relationship | Existential restriction modifier | ||
Berotralstat hydrochloride | Has disposition | Kallikrein inhibitor | true | Inferred relationship | Existential restriction modifier | ||
Berotralstat hydrochloride | Is modification of | Berotralstat | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely berotralstat (as berotralstat hydrochloride) 150 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Berotralstat hydrochloride | Inferred relationship | Existential restriction modifier | 1 |
Product containing precisely berotralstat (as berotralstat hydrochloride) 110 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Berotralstat hydrochloride | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets